MentionFox
Home › funding signals › NurExone Biologic Inc.
Company · SEC filings

NurExone Biologic Inc. funding history

NurExone Biologic Inc. has 11 Form D filings on record, from 2023-10-02 to 2026-08-21. Together its new offerings report $1.32M sold.

Funding historyFounders and team

What do you want to do with NurExone Biologic Inc.?

Based
TECHNION CITY, HAIFA, ISRAEL
Year formed
2025
Industry group
Biotechnology
Filings
11
Raised (new offerings)
$1.32M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-08-21New offering
first sale 2026-08-20
$450K$450Kdetails · SEC filing
2026-07-02New offering
first sale 2026-06-30
$442K$442KSEC filing
2026-03-18New offering
first sale 2026-03-10
$280K$280KSEC filing
2025-08-27New offering
first sale 2025-08-20
$148K$243KSEC filing
2025-04-22Filing——SEC filing
2025-01-22Filing——SEC filing
2024-03-25Filing——SEC filing
2024-03-25Filing——SEC filing
2024-03-25Filing——SEC filing
2024-01-09Filing——SEC filing
2023-10-02Filing——SEC filing

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from NurExone Biologic Inc.'s own filings with the SEC. The people those filings name are on the team page.

Cite this page

Permanent URL: https://mentionfox.com/company/nurexone-biologic-inc
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
NurExone Biologic Inc. funding history: 11 SEC filings, $1.32M raised. MentionFox, 2026-09-26. https://mentionfox.com/company/nurexone-biologic-inc